L’Oréal invests in Timeline, a Swiss biotech company specializing in longevity

Translated by Roberta HERRERA Published Jan 18, 2024 Global beauty giant L’Oréal, through its venture capital fund Bold, has recently acquired a minority stake in Timeline, a Swiss biotechnology company specializing in longevity. A mitochondrion – L’Oréal Established in 2007 by Chris Rinsch and Patrick Aebischer, as a spin-off from the École Polytechnique Fédérale de [...]read moreL’Oréal invests in Timeline, a Swiss biotech company specializing in longevity